Cdr-Life Inc.

Cdr-Life Inc. company information, Employees & Contact Information

Explore related pages

Related company profiles:

At CDR-Life, we are on a mission to transform antibody science into life-changing therapies. Our innovative T cell engager (TCE) platform, M-gager®, delivers therapeutics against challenging targets with unprecedented precision, speed and efficiency. For cancer patients, we are advancing a pipeline of potent and selective TCEs targeting intracellular and surface antigens that empower patients’ own immune systems to eliminate tumors, and our first program has entered the clinic. In autoimmune diseases, we're using this same breakthrough approach to reset overactive immune responses with pinpoint accuracy. Our platform combines optimized manufacturability with deep scientific expertise and cutting-edge engineering, enabling rapid translation from discovery to scalable production of these complex biologics. This integrated approach helps accelerate the journey from lab to patient treatment, making once-impossible therapeutic goals both achievable and deliverable at scale.

Company Details

Employees
69
Founded
-
Address
Tödistrasse 46, Horgen,zurich 8810,switzerland
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Horgen, Zurich
Looking for a particular Cdr-Life Inc. employee's phone or email?

Cdr-Life Inc. Questions

News

CDR-Life Announces CDR609 as New T-Cell Engager Clinical Candidate Targeting LGR5, a Highly Cancer-specific Surface Antigen Widely Expressed on Common Solid Tumor - Business Wire

CDR-Life Announces CDR609 as New T-Cell Engager Clinical Candidate Targeting LGR5, a Highly Cancer-specific Surface Antigen Widely Expressed on Common Solid Tumor Business Wire

CDR-Life Demonstrates Commitment to Differentiated Pipeline with New Autoimmune Candidate CDR111 - Yahoo Finance

CDR-Life Demonstrates Commitment to Differentiated Pipeline with New Autoimmune Candidate CDR111 Yahoo Finance

CDR-Life completes fifth milestone and is recruiting patients for Phase 2 study of BI 771716 - Modern Retina

CDR-Life completes fifth milestone and is recruiting patients for Phase 2 study of BI 771716 Modern Retina

EU To Fund CDR Under The 2025 Edition Of Its LIFE Program - Carbon Herald

EU To Fund CDR Under The 2025 Edition Of Its LIFE Program Carbon Herald

MAGE-A4 T-Cell Engager Cleared for Phase 1 Trial in Solid Tumors - CGTLive®

MAGE-A4 T-Cell Engager Cleared for Phase 1 Trial in Solid Tumors CGTLive®

From Startup Survival to Pandemic Response: Tina Vidal-Duart's Leadership at CDR Health Is Changing Lives - International Business Times

From Startup Survival to Pandemic Response: Tina Vidal-Duart's Leadership at CDR Health Is Changing Lives International Business Times

Swiss biotech CDR Life uses $76M series A funding round to ready T-cell engagers for clinic - Fierce Biotech

Swiss biotech CDR Life uses $76M series A funding round to ready T-cell engagers for clinic Fierce Biotech

Boehringer and CDR-Life report data from geographic atrophy treatment trial - Clinical Trials Arena

Boehringer and CDR-Life report data from geographic atrophy treatment trial Clinical Trials Arena

CDR-813 demonstrates high target-specific binding and antitumor potency in preclinical models - BioWorld MedTech

CDR-813 demonstrates high target-specific binding and antitumor potency in preclinical models BioWorld MedTech

Alzheimer Disease Agent Lecanemab Shows Reduction in CDR-Sum of Boxes in Clarity AD - NeurologyLive

Alzheimer Disease Agent Lecanemab Shows Reduction in CDR-Sum of Boxes in Clarity AD NeurologyLive

Boehringer Ingelheim to advance potential new treatment for geographic atrophy following positive Phase I results - Ophthalmology Times

Boehringer Ingelheim to advance potential new treatment for geographic atrophy following positive Phase I results Ophthalmology Times

Another Roche MAGE-A4 trial disappears, withdrawn without enrolling after strategic review - Fierce Biotech

Another Roche MAGE-A4 trial disappears, withdrawn without enrolling after strategic review Fierce Biotech

Boehringer nabs Northern Biologics preclinical assets, pens eye disease drug pact - Fierce Biotech

Boehringer nabs Northern Biologics preclinical assets, pens eye disease drug pact Fierce Biotech

CDR scam: Udita Goswami asked for call data of her husband Mohit Suri? - Bollywood Life

CDR scam: Udita Goswami asked for call data of her husband Mohit Suri? Bollywood Life

Top Cdr-Life Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant